To investigate the impact of USP9x on tumor growth, in vitro and in vivo proliferation assays were performed by using doxycycline-inducible shRNA-expressing NCI-H1975 lung cancer cell lines, targeting the USP9x gene or a non-targeting control (Fig. 2A). The gene discussed is USP9X; the disease is neoplasm.